AASMNAR09212c
Source
Republished with permission of American Academy of Sleep Medicine (AASM), from the
Journal of Clinical Sleep Medicine, the official journal of AASM. Maski K, Trotti LM, Kotagal
S, Robert Auger R, Rowley JA, Hashmi SD, Watson NF. Treatment of central disorders of
hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline. J Clin
Sleep Med. 2021 Sep 1;17(9):1881-1893
Disclaimer
is pocket guide attempts to define principles of practice that should produce high-quality patient
care. It is applicable to specialists, primary care, and providers at all levels. is pocket guide should
not be considered exclusive of other methods of care reasonably directed at obtaining the same
results. e ultimate judgment concerning the propriety of any course of conduct must be made by
the clinician aer consideration of each individual patient situation. Neither IGC, the medical
associations, nor the authors endorse any product or service associated with the distributor of this
clinical reference tool.
Strength of Recommendation and Quality of Evidence
Grade Strength Implication
S Strong
recommendation:
"We recommend…"
Almost all patients should receive the recommended
course of action. Adherence to this recommendation could
be used as a quality criterion or performance indicator.
C Conditional
recommendation:
"We suggest…"
Most patients should receive the suggested course of
action; however, different choices may be appropriate for
different patients. e clinician must help each patient
determine if the suggested course of action is clinically
appropriate and consistent with his or her values and
preferences.
The distribution of this educational resource was supported by Avadel
CNS Pharmaceuticals, LLC. Avadel was not involved in the development
of the underlying guidelines on which this pocket guide is based.
To access this pocket guide online,
visit GuidelineCentral.com/Narcolepsy
PM-US-SXB-0355
